NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (APUS) and Mindwave ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: ...

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced the closing of its previously announced $100 million private investment in public equity (PIPE) financing. This substantial ...

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy Apimeds Pharmaceuticals US, Inc.

Magic of Rahat teaches crazy mind reading card tricks in a tutorial A ‘Trump class’ folly on the high seas 'Robbing them': Treasury slams states over Trump tax cuts ICC faces turmoil amid ...

Watch Full Movie on Digital or Stream on Demand starting December 6th, 2024 ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

MATAWAN, N.J. - Apimeds Pharmaceuticals US, Inc. (NYSE American:APUS) announced Monday it has signed a merger agreement with MindWave Innovations Inc., creating a company that combines ...

Apimeds Pharmaceuticals US, Inc. (APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio ...